Shanghai Biotech Cataya Secures $35 Million in Series B Financing for Synthetic Biology
Shanghai-based biotech company Cataya, which specializes in synthetic biology, has reportedly raised RMB 250 million...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity